Keyphrases
PGF2
100%
Hepatorenal Syndrome
100%
Obeticholic Acid
100%
Bile Duct Ligation
55%
Acid Treatment
33%
Sham
22%
Cyclooxygenase-1 (COX-1)
22%
Receptor Agonist
22%
Thromboxane A2 (TXA2)
22%
Oxidative Stress
11%
Reactive Oxygen Species
11%
Apoptosis
11%
Stress Release
11%
Incubation
11%
Stress-related
11%
Cell Apoptosis
11%
Perfused Rat Kidney
11%
Acid Groups
11%
Anti-apoptotic
11%
Tubular Injury
11%
Serum Creatinine
11%
Kidney Injury
11%
Induced Oxidative Stress
11%
In Vitro Experiment
11%
Urine Output
11%
NRK-52E Cells
11%
Chronic Treatment
11%
Vasodilator
11%
Glomerular Filtration Rate
11%
Ascites
11%
Rat Kidney
11%
Systemic Hemodynamics
11%
Portal Hypertension
11%
Renal Vascular Resistance
11%
Renal Hemodynamics
11%
Renal Abnormalities
11%
Hyperresponsiveness
11%
Splanchnic Hemodynamics
11%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
11%
Renal Blood Flow
11%
Renal Oxidative Stress
11%
Hepatic Abnormalities
11%
Anti-oxidative Stress
11%
Biochemistry, Genetics and Molecular Biology
Oxidative Stress
100%
Receptor Agonists
66%
Cyclooxygenase
66%
Kidney Blood Flow
66%
Thromboxane A2
66%
Programmed Cell Death
66%
Downregulation
33%
Gelatinase
33%
Glomerulus Filtration
33%
Creatinine Blood Level
33%
Kidney Vascular Resistance
33%
Lipocalin
33%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatorenal Syndrome
100%
Obeticholic Acid
100%
Receptor Agonist
22%
Prostaglandin Synthase
22%
Thromboxane A2
22%
Reactive Oxygen Metabolite
11%
Antioxidant
11%
Antiapoptotic
11%
Creatinine
11%
Kidney Injury
11%
Placebo
11%
Ascites
11%
Portal Hypertension
11%
Neutrophil Gelatinase Associated Lipocalin
11%